<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04250906200509</udiDi>
    <basicUdiDi>42509062IALSQ</basicUdiDi>
    <tradeName>ViscoPhi %2.2</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI222DE-VSP</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T13:46:13.448Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200165</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>ViscOge</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI301DE-VSG</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-17T13:46:11.627Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200158</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>ViscOge</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI221DE-VSG</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-17T13:46:10.717Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200141</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>ViscOge</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI181DE-VSG</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-17T13:46:09.850Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200134</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>ViscOge</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI161DE-VSG</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-17T13:46:08.921Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200127</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>ViscOge</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI141DE-VSG</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-17T13:46:08.007Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200110</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>ViscOge</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI101DE-VSG</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T13:46:07.108Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200073</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>VisOcu</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI221DE-VSO</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-17T13:46:00.091Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200066</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>VisOcu</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI181DE-VSO</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T13:45:59.184Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200059</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>VisOcu</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI161DE-VSO</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-17T13:45:58.294Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200042</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>VisOcu</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI141DE-VSO</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T13:45:57.387Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200080</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>VisOcu</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-28T22:23:14.628Z</lastUpdated>
  </row>
</eudamedExport>